Home / Private raises / Cellphire, Inc.
Cellphire, Inc.
Biotechnology · Rockville, Maryland · $6.5M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | D (new) | $6.5M | $8.0M | 22 | 506(c) | Equity | Oct 30 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Issuer
| Industry | Biotechnology |
| Located | Rockville, Maryland |
| Entity | Corporation |
| Incorporated | Delaware |
| Minimum investment | $1K |
| SEC CIK | 1815181 |
People named in the latest filing
| Name | Role |
|---|---|
| Michael Gaffney | Executive Officer, Director |
| James Peake | Director |
| Thomas Dubin | Director |
| Pamela Conley | Director |
| Randall Stanicky | Director |
| Derek Woods | Director |
| Rafael Jorda | Director |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
